420 related articles for article (PubMed ID: 19877067)
1. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
[TBL] [Abstract][Full Text] [Related]
2. Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation syndrome?
Campos LM; Omori CH; Lotito AP; Jesus AA; Porta G; Silva CA
Lupus; 2010 Dec; 19(14):1654-8. PubMed ID: 20837568
[TBL] [Abstract][Full Text] [Related]
3. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Ravelli A; Magni-Manzoni S; Pistorio A; Besana C; Foti T; Ruperto N; Viola S; Martini A
J Pediatr; 2005 May; 146(5):598-604. PubMed ID: 15870661
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
5. [Macrophage activation syndrome in lupus].
Javier RM; Sibilia J; Offner C; Albert A; Kuntz JL
Rev Rhum Ed Fr; 1993 Nov; 60(11):831-5. PubMed ID: 8054932
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?
Pringe A; Trail L; Ruperto N; Buoncompagni A; Loy A; Breda L; Martini A; Ravelli A
Lupus; 2007; 16(8):587-92. PubMed ID: 17711893
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation syndrome: A severe and frequent manifestation of acute pancreatitis in 362 childhood-onset compared to 1830 adult-onset systemic lupus erythematosus patients.
Gormezano NW; Otsuzi CI; Barros DL; da Silva MA; Pereira RM; Campos LM; Borba EF; Bonfá E; Silva CA
Semin Arthritis Rheum; 2016 Jun; 45(6):706-10. PubMed ID: 26833399
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
9. The incidence of macrophage activation syndrome in children with rheumatic disorders.
Moradinejad MH; Ziaee V
Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
[TBL] [Abstract][Full Text] [Related]
10. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement.
Ruperto N; Ravelli A; Oliveira S; Alessio M; Mihaylova D; Pasic S; Cortis E; Apaz M; Burgos-Vargas R; Kanakoudi-Tsakalidou F; Norambuena X; Corona F; Gerloni V; Hagelberg S; Aggarwal A; Dolezalova P; Saad CM; Bae SC; Vesely R; Avcin T; Foster H; Duarte C; Herlin T; Horneff G; Lepore L; van Rossum M; Trail L; Pistorio A; Andersson-Gäre B; Giannini EH; Martini A;
Arthritis Rheum; 2006 Jun; 55(3):355-63. PubMed ID: 16739203
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
[TBL] [Abstract][Full Text] [Related]
12. Hematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children.
Gokce M; Bilginer Y; Besbas N; Ozaltin F; Cetin M; Gumruk F; Ozen S
Lupus; 2012 Jul; 21(8):878-84. PubMed ID: 22495873
[TBL] [Abstract][Full Text] [Related]
13. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Childhood Health Assessment Questionnaire in active juvenile systemic lupus erythematosus.
Meiorin S; Pistorio A; Ravelli A; Iusan SM; Filocamo G; Trail L; Oliveira S; Cuttica R; Espada G; Alessio M; Mihaylova D; Cortis E; Martini A; Ruperto N;
Arthritis Rheum; 2008 Aug; 59(8):1112-9. PubMed ID: 18668598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
